Market Overview Intensity Modulated Radiotherapy Market size was valued at USD 1.70 billion in 2023. The market is anticipated to grow from USD 1.76 billion in 2024 to USD 2.59 billion by 2032, exhibiting the CAGR of 5.0% during the forecast period. The adoption of IMRT has been accelerating due to its ability to improve treatment outcomes, reduce side effects, and enhance...

Market Overview Intensity Modulated Radiotherapy Market size was valued at USD 1.70 billion in 2023. The market is anticipated to grow from USD 1.76 billion in 2024 to USD 2.59 billion by 2032, exhibiting the CAGR of 5.0% during the forecast period. The adoption of IMRT has been accelerating due to its ability to improve treatment outcomes, reduce side effects, and enhance...

  The AACR Annual Meeting 2025 is a globally recognized event that brings together leading experts, researchers, and healthcare professionals to share groundbreaking discoveries in cancer research. As one of the most anticipated conferences in oncology, it provides a platform for unveiling the latest advancements in cancer treatments, diagnostics, and cutting-edge therapies. Attendees will...

The AACR Annual Meeting 2025 is a prestigious global event where leading oncologists, scientists, and industry pioneers come together to discuss groundbreaking advancements in cancer research. Organized by the American Association for Cancer Research (AACR), the conference covers cutting-edge innovations in immunotherapy, precision medicine, and targeted therapies. With expert discussions and...

Overview of the Acute Myeloid Leukemia Treatment Market The acute myeloid Leukemia treatment market is centered on therapies and diagnostic solutions for AML, a cancer of the blood and bone marrow characterized by rapid proliferation of abnormal myeloid cells. The increasing prevalence of leukemia, particularly among children and older adults, has made early diagnosis and effective treatment...

1. Introduction Adult malignant glioma represents one of the most aggressive and fatal forms of brain cancer, characterized by rapid progression and poor prognosis. This type of tumor primarily affects adults over 45 years of age and poses significant challenges for patients, caregivers, and healthcare systems globally. Malignant gliomas, including glioblastoma multiforme (GBM) and anaplastic...

During the forecast period, the size of the worldwide olfactory neuroblastoma market is anticipated to expand steadily in terms of revenue CAGR. The market is expanding as a result of a number of key factors, including the increased incidence of cancer and the number of clinical trials and research for the treatment of olfactory neuroblastoma. Additionally, the industry's revenue growth is...

The HER3 inhibitors Market constitutes an emerging therapeutic frontier within cancer medicine, propelled by revolutionary scientific insights, refined patient selection approaches, and intensified focus on addressing therapeutic resistance pathways. HER3 (ErbB3), formerly regarded as a catalytically inactive component of the ErbB receptor network, has emerged as a critical mediator of adaptive...

Polaris Market Research announces the release of its latest research report titled, Attention Deficit Hyperactivity Disorder Market. The report offers an in-depth analysis of the global market. It outlines current market conditions and future growth potential over the forecast period. It includes comprehensive data-backed insights into emerging trends, innovation pipelines, and competitive...

    Alfa Cytology introduces comprehensive molecule PARPi d development services for combating  various diseases .   Alfa Cytology, a developer of oncology innovation, has announced its latest venture small molecule Poly(ADP-ribose) polymerase inhibitor development services. This cutting-edge initiative represents a major advancement in creating more precise and versatile...